拥有健康的消化道对维持人体整体健康非常重要；而了解复杂的消化过程，对了解维持健康的消化道如何能维持整体健康也非常重要。

NutriClean先进纤维粉含有可溶纤维和益生菌。此配方中的纤维及益生菌相互合作维持消化道健康。NutriClean先进纤维粉不单提供可溶纤维，还提供有益健康的益生菌，益生菌能维持肠道内的益菌数量，保持肠内微生物的平衡。众所皆知，理想的健康从身体内部的清洁开始，而NutriClean先进纤维粉可帮助您实现此理想！

左旋麸醯胺酸
高蛋白质的食物，包括肉类、鱼类、豆类及乳制品，都是麸醯胺酸的极佳来源。左旋麸醯胺酸是一种胺基酸，为肠道的燃料来源。由于肠道细胞以麸醯胺酸为燃料，因此补充左旋麸醯胺酸可促进消化健康。

菊糖
菊糖是由许多类型的植物产生的、天然存在的多醣类。它被认为是一种可溶性纤维形式，有时也被归类为一种益生元，这意味着它可以被消化道内的细菌用作为食物。菊糖或果寡糖(FOS)是淀粉形式的纤维，不能被人体完全消化。当人摄取益生元时，未能消化的部分便为消化道中的有益菌提供营养。菊糖可以促进有益菌群的生长，例如结肠中的双叉杆菌。

Fibersol-2（可溶纤维葡萄糖聚合物复合物）
Fibersol-2是一种可溶性纤维， 支援消化道健康。这种食用纤维是透过将玉米淀粉高温分解及稳定酵素水解而制成的喷雾风干粉末。因为它天然地大量存在于化学键中，并在消化道中保持未消化的状态，有助于支援整体健康。

益生菌混合物（包括嗜乳酸杆菌、胚芽乳酸杆菌、双歧双叉杆菌及酪蛋白乳酸杆菌）
益生菌诸如嗜酸乳杆菌此类细菌是已知的“有益”或“好”的细菌。这些有益菌实际上有助维持健康的消化道。消化系统自然地容纳了数以百万计的有益菌。这类菌群经常受到破坏，因此我们应采取措施使他们保持在足够的水平上，以维持消化健康。有益菌天然存在于食物中，例如发酵的优格和克弗乳（kefir）。益生菌有助支援整体健康及维持肠道平衡。

为什么结肠的保健如此重要? 
很少人真正留意他们的消化系统，直到身体出现一些明显的问题，如涨气、消化不良、排便不规律或腹泻等。然而，这些看似普通的现象也许是身体出现问题的征兆，使人们正视结肠与消化系统保健的重要性。现代人的饮食被公认为含有高脂肪及高热量，而现代人的生活方式更是无益于结肠的健康。日子久了，缺乏某些营养素和纤维素的饮食习惯，会减慢未消化食物在结肠内的输送时间，因而导致一些健康问题。这样的结果足以让大家关注维持结肠健康。

NutriClean先进纤维粉和一般市面商店购买的纤维粉有何不同？
NutriClean先进纤维粉是肠道健康的革命性创新产品。大多数超市和药房售卖的纤维产品，都或有助通便，然而却缺少了一些重要成份。NutriClean先进纤维粉，不像巿面一般的纤维粉仅含简单的助泻纤维，NutriClean先进纤维粉不但含菊糖和Fibersol-2，也含称为左旋麸醯胺酸 (L-Glutamine)的养份，为消化系统运作提供能量来源。我们的纤维粉配方含有15亿菌落数的益生菌微生物，在保持整体健康上担当不可或缺的角色。

为什么纤维对整体健康如此重要? 
很不幸的是，现代人的生活方式使得一般人从他们的饮食中没有获得足够的纤维素。这绝不是好事，因为纤维事实上应该是饮食中最重要的构成要素之一，然而却往往被人们忽略了。纤维的益处包括促进肠道蠕动、增加饱肚感及维持肠道运作的规律性。

如何饮用NutriClean先进纤维粉？
将一圆匙（12.2克）的NutriClean先进纤维粉加入一杯240毫升的冷开水中加以搅拌，并即时饮用。使用本品时请多饮水。

什么是贮存NutriClean先进纤维粉的最佳方式？
贮存于阴凉、干燥处，如冰箱或防潮箱内。

Fibersol-2是什么？
Fibersol-2是一种支援消化道健康的可溶纤维。这种食用纤维是透过玉米粉高温分解及稳定酵素水解而制成的喷雾风干粉末。Fibersol-2含有大量不会于消化道内消化的天然化学键，因此有助支援整体健康。

益生菌(probiotics)是什么？
益生菌(probiotics)是一种细菌。NutriClean先进纤维粉中所含的益生菌能抗衡多余的有害细菌，为最佳的整体保健铺下健康之路。益生菌被发现有助于维持消化道健康。NutriClean先进纤维粉中每一份含有15亿菌落数的益生菌，包括嗜乳酸杆菌(Lactobacillus acidophilus)、胚芽乳酸杆菌(Lactobacillus plantarum)、酪蛋白乳酸杆菌(Lactobacillus casei) 以及双歧双叉杆菌(Bifodobacterium bifidum)。

NutriClean先进纤维粉是素食产品吗？
是。

NutriClean先进纤维粉是在符合良好生产规范(GMP)的设备中生产的吗？
是的，本产品在美国制造，并在经美国食品及药物管理局(FDA)检测的设备生产，符合良好生产规范。 

(Fibersol-2)

• Satouchi M et al, "Effects of indigestible dextrin on bowel movements," Japanese J Nutr , 51:31-37, 1993.
• Tokunaga K and Matsuoka A, "Effects of a [FOSHU] which contains indigestible dextrin as an effective ingredient on glucose and lipid metabolism," J Japanese Diabetes Society , 42:61-65, 1999.
• Wakabayashi S et al, "Effects of indigestible dextrin on glucose tolerance in rats," J Endocrinology , 144:533-538, 1995.
• Watanabe O et al, "Effects of galacto-oligosaccharide and indigestible dextrin on fat accumulation in broiler," Japanese Poultry Science , 30:35, 1993.

(Inulin)

• Brighenti F, Casiraghi MC, Canzi E, Ferrari A. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr. 1999; 53:726-733.
• Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther . 2001;15:1139–1145.
• Davidson MH, Synecki C, Maki KC, Drennen KB. Effects of dietary inulin in serum lipids in men and women with hypercholesterolaemia. Nutr Res . 1998;3:503–17.
• Ducros V, Arnaud J, Tahiri M, et al. Influence of short-chain fructo-oligosaccharides (sc-FOS) on absorption of Cu, Zn, and Se in healthy postmenopausal women. J Am Coll Nutr . 2005;24:30–7.
• Giacco R, Clemente G, Luongo D, et al. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr . 2004;23:331–40.
• Jackson KG, Taylor GRJ, Clohessy AM, Williams CM. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr . 1999;82:23–30.
• Menne E, Guggenbuhl N, Roberfroid M. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J Nutr. 2000; 130:1197-1199.
• Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr . 2000;72:1570–5.
• Pedersen A, Sandstrom B, van Amelsvoort JMM. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr . 1997;78:215–22.
• Reddy BS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis. 1997; 18:1371-1374.
• Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev Nutr. 1998; 18:117-143.
• Roberfroid MB, Van Loo JA, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998; 128:11-19.
• Schaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr . 1998;52:436–40.
• Tahiri M, Tressol JC, Arnaud J, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study. Am J Clin Nutr . 2003;77:449–457.
• Tahiri M, Tressol JC, Arnaud J, et al. Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res . 2001;16:2152–2160.
• van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EG. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr . 99;53:1–7.
• Waligora-Dupriet AJ, Campeotto F, Nicolis I et al. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int J Food Microbiol . 2006 Sep 20 [Epub ahead of print]
• Williams CM. Effects of inulin on lipid parameters in humans. J Nutr. 1999; 129(7 Suppl):1471S-1473S.
• Williams CM, Jackson KG. Inulin and oligofructose: effects on lipid metabolism from human studies. Br J Nutr . 2002;87(suppl 2):S261–4.

(L-Glutamine)

• Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr . 2000;30:78–84.
• Alverdy JC. Effects of glutamine-supplemented diets on immunology of the gut. JPEN J Parenter Enteral Nutr .1990;14(suppl 4):109S–113S.
• Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001;48:28–33.
• Den Hond E, Hiele M, Peeters M, et al. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. JPEN J Parenter Enteral Nutr . 1999;23:7–11.
• Fox AD, Kripke SA, Berman JR, et al. Reduction of the severity of enterocolitis by glutamine-supplemented enteral diets. Surg Forum . 1987;38:43–44.
• Fujita T, Sakurai K. Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg . 1995;82:749–751.
• Garcia-de-Lorenzo A, Zarazaga A, Garcia-Luna PP, et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition . 2003;19:805-11.
• Huffman FG, Walgren ME. L-Glutamine supplementation improves nelfinavir-associated diarrhea in HIV-infected individuals. HIV Clin Trials . 2003;4:324-9. gut integrity. Lancet . 1993;341:1363–1365.
• Shabert JK, Winslow C, Lacey JM, et al. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. Nutrition . 1999;15:860–864.
• van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. 1993 May 29;341(8857):1363-5.
• Yang C, Li N, Li JS. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol . 2004;10:1992-4.
• Zoli G, Care M, Falco F, et al. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn's disease [abstract]. Gastroenterology . 1995;108:A766.

(Probiotic Blend)

• Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr. 2000 Apr;54(4):288-97.
• Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000 Mar;54(3):263-7.
• Barone C, Pettinato R, Avola E, Alberti A, Greco D, Failla P, Romano C. Comparison of three probiotics in the treatment of acute diarrhea in mentally retarded children. Minerva Pediatr. 2000 Mar;52(3):161-5.
• Bengmark S. Bacteria for optimal health. Nutrition. 2000 Jul-Aug;16(7-8):611-5.
• Bengmark S. Colonic food: pre- and probiotics. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S5-7.
• Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998 Jan;42(1):2-7.
• Biancone L, Pallone F. Current treatment modalities in active Crohn's disease. Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):508-14.
• Brady LJ, Gallaher DD, Busta FF. The role of probiotic cultures in the prevention of colon cancer. J Nutr. 2000 Feb;130(2S Suppl):410S-414S.
• Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S18-22.
• Cerrato PL. Can "healthy" bacteria ward off disease? RN. 2000 Apr;63(4):71-4.
• Chin J, Turner B, Barchia I, Mullbacher A. Immune response to orally consumed antigens and probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):55-66.
• Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999 May;69(5):1052S-1057S.
• Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L, Califano C, Dunn AM, Grassey C, Hinds G, Cervia J. Probiotics and immune response. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S22-5.
• D'Argenio G, Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol. 1999;472:149-58.
• Davidson GP, Butler RN. Probiotics in pediatric gastrointestinal disorders. Curr Opin Pediatr. 2000 Oct;12(5):477-81.
• de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000 Feb;71(2):405-11.
• Dugas B, Mercenier A, Lenoir-Wijnkoop I, Arnaud C, Dugas N, Postaire E. Immunity and probiotics. Immunol Today. 1999 Sep;20(9):387-90.
• Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):279-92.
• Dupont C. Bacterial flora in the infant and intestinal immunity: Implication and prospects for infant food with probiotics. Arch Pediatr. 2000 May;7 Suppl 2:252s-255s.
• Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr. 2000 Feb;130(2S Suppl):403S-409S.
• Folwaczny C. Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment? Z Gastroenterol. 2000 Jun;38(6):547-50.
• Friedrich MJ. A bit of culture for children: probiotics may improve health and fight disease. JAMA. 2000 Sep 20;284(11):1365-6.
• Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr. 2000 Feb;130(2S Suppl):391S-395S.
• Gibson GR, McCartney AL. Modification of the gut flora by dietary means. Biochem Soc Trans. 1998 May;26(2):222-8.
• Gismondo MR, Drago L, Lombardi A. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents. 1999 Aug;12(4):287-92.
• Goldin BR. Health benefits of probiotics. Br J Nutr. 1998 Oct;80(4):S203-7.
• Gomez-Gil B, Roque A, Turnbull JF, Inglis V. A review on the use of microorganisms as probiotics. Rev Latinoam Microbiol. 1998 Jul-Dec;40(3-4):166-72.
• Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S2-4.
• Guslandi M. The relationship between gut microflora and intestinal inflammation. Can J Gastroenterol. 2000 Jan;14(1):32.
• Heyman M. Effect of lactic acid bacteria on diarrheal diseases. J Am Coll Nutr. 2000 Apr;19(2 Suppl):137S-146S.
• Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000 May;2(6):681-6.
• Hoerr RA, Bostwick EF. Bioactive proteins and probiotic bacteria: modulators of nutritional health. Nutrition. 2000 Jul-Aug;16(7-8):711-3.
• Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview of gut flora and probiotics. Int J Food Microbiol. 1998 May 26;41(2):85-101.
• Hove H, Norgaard H, Mortensen PB. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr. 1999 May;53(5):339-50.
• Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999 Summer;3(4):197-202.
• Isolauri E. The use of probiotics in paediatrics. Hosp Med. 2000 Jan;61(1):6-7.
• Kasper H. Protection against gastrointestinal diseases--present facts and future developments. Int J Food Microbiol. 1998 May 26;41(2):127-31.
• Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics--a novel approach in the management of food allergy. Allergy. 1999 Sep;54(9):909-15.
• Klaenhammer TR. Probiotic bacteria: today and tomorrow. J Nutr. 2000 Feb;130(2S Suppl):415S-416S. 40. Kochhar KP. Probiotics and gastrointestinal function in health and disease. Trop Gastroenterol. 2000 Jan-Mar;21(1):8-11.
• LaMont JT. The renaissance of probiotics and prebiotics. Gastroenterology. 2000 Aug;119(2):291.
• Levy J. Immunonutrition: the pediatric experience. Nutrition. 1998 Jul-Aug;14(7-8):641-7. 43. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ. 1999 Apr 10;318(7189):999-1003.
• Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):67-73.
• Orrhage K, Nord CE. Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res. 2000;26(3):95-111.
• Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S, Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol. 2000 Jan;30(1):10-3.
• Reddy BS. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr. 1999 Jul;129(7 Suppl):1478S-82S.
• Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol. 1999 Sep;65(9):3763-6.
• Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000 Jun;71(6 Suppl):1682S-7S; discussion 1688S-90S.
• Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000 Feb;130(2S Suppl):396S-402S.
• Saavedra JM. Probiotics plus antibiotics: regulating our bacterial environment. J Pediatr. 1999 Nov;135(5):535-7.
• Sanders ME. Considerations for use of probiotic bacteria to modulate human health. J Nutr. 2000 Feb;130(2S Suppl):384S-390S.
• Shanahan F. Immunology. Therapeutic manipulation of gut flora. Science. 2000 Aug 25;289(5483):1311-2.
• Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis. 2000 May;6(2):107-15.
• Studd C. Probiotic containing fermented milk supplement may improve the institution of early enteral nutrition. Crit Care Med. 2000 Apr;28(4):1255-6.
• Szilagyi A. Prebiotics or probiotics for lactose intolerance: a question of adaptation. Am J Clin Nutr. 1999 Jul;70(1):105-6.
• Taylor GR, Williams CM. Effects of probiotics and prebiotics on blood lipids. Br J Nutr. 1998 Oct;80(4):S225-30.
• Torrens JK, McWhinney PH. Probiotics and life-threatening infection. J Infect. 1999 Nov;39(3):246.
• Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999 Nov;135(5):564-8.
• Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 1998 Sep;27(3):323-32.
• Vanderhoof JA. Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S34-8.
• Vilpponen-Salmela T, Alander M, Satokari R, Bjorkman P, Kontula P, Korpela R, Saxelin M, Mattila-Sandholm T, von Wright A. Probiotic bacteria and intestinal health: new methods of investigation. J Physiol Paris. 2000 Mar-Apr;94(2):157-8.
• von Wright A, Salminen S. Probiotics: established effects and open questions. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1195-8.
• Yasui H, Shida K, Matsuzaki T, Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):383-9.
• Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Gopal PK, Gill HS. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol. 2000 Feb-Mar;38(2-3):153-61.